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Measuring sedentary behaviours in patients with idiopathic pulmonary 
fibrosis using wrist-worn accelerometers 
Abstract 
Introduction - Idiopathic pulmonary fibrosis (IPF) patients suffer increasing functional limitation with 
disease worsening disease. Increasing time in sedentary behaviour has been associated with poorer 
quality of life. Determining thresholds for activity in patients with respiratory disease is difficult due 
to variable cardiorespiratory limitations between individuals. Measuring sedentary behaviour is not 
confounded by this limitation and may be a better measurement of activity in patients with 
respiratory disease.  
Objectives – To measure sedentary time in patients with IPF using wrist-worn accelerometers. 
Methods – 39 IPF patients wore a GENEActiv actiwatch continually for 7 days. Participants 
underwent measurement of forced vital capacity, diffusion capacity of carbon monoxide and 6 
minute walk distance. 
Results – Valid data was captured from 35 of 39 participants (89.7%). Mean acceleration intensity 
recorded in the most active 5 hours of each day (in milli-g) were 43.8milli-g and sedentary time was 
551.7 minutes per day. Daily sedentary time correlated moderately with M5 values (Pearson 
correlation -0.366, p=0.030). Only M5 values predicted sedentary time. No variability in sedentary 
time was seen by day of the week. There was a trend towards higher one and two-year mortality 
with increasing sedentary time. 
Conclusions – Wrist-worn accelerometers reliably collected data and were well tolerated. IPF 
patients spent long periods of time in sedentary behaviours. Of the standard clinical measures used, 
6MWD predicted daily activity but not sedentary time; no clinical measures predicted sedentary 
time. Increased sedentary time may be associated with poorer outcomes in IPF patients. 
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Introduction 
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) of unknown 
cause1. Affected lungs show characteristic fibrosis, with progressive impairment of gas transfer leading 
to exercise-induced dyspnoea2 and reduced physical activity in daily life3. Physical activity is associated 
with numerous health benefits4. However, it is becoming increasingly apparent that prolonged time 
in sedentary behaviours, inactivity defined as a combination of sitting and low levels of energy 
expenditure5, has negative effects on health even if recommendations on physical activity levels are 
met6-8. This may be of particular importance in patients with chronic lung diseases, including IPF, 
where achieving recommended levels of moderate or vigorous physical activity may be unrealistic due 
to exertional dyspnoea and fatigue9.  
 
Daily activity in free-living conditions can be measured over a period of several days using multi-axis 
accelerometers. The accuracy of these devices to estimate energy expenditure compared with indirect 
calorimetry or doubly labelled water has been investigated in certain chronic lung diseases10 but not 
in patients with interstitial diseases like IPF. However, wrist-worn accelerometers are also able to 
measure sedentary behaviours using postural data 11. In contrast to the difficulties of classifying 
activity vigour using accelerometer outputs in disease, we hypothesised that the accuracy of 
measuring sedentary behaviour time with these devices should not significantly vary between health 
and disease. Our rationale for this was that the definition of sedentary behaviours will not alter in 
patients with chronic disease as the two defining aspects of sedentary behaviours (sitting position and 
low energy state) should remain unchanged even with marked cardiorespiratory limitation.  
 This study investigates the feasibility of using a wrist-worn, three-axis accelerometer as a measure of 
daily physical activity and time in sedentary behaviours in patients with IPF, and evaluates the 
associations between time spent in sedentary behaviours and lung function, six minute walk distance 
(6MWD) and questionnaire measures of dyspnoea, depression and anxiety, fatigue and quality of life, 
as well as accelerometer outputs for activity levels. 
 
Methods 
Subjects 
Patients with a diagnosis of definite or probable IPF based on high resolution CT criteria1, or lung 
biopsy confirming usual interstitial pneumonia (UIP) without an alternative cause, were approached 
in the respiratory clinic at Norfolk and Norwich University Hospital, Norfolk UK. Ethical approval was 
given by South Central – Oxford C research ethics committee (reference number 13/SC/0116). 
Patients were excluded if they had significant cardiac or pulmonary disease contributing to their 
symptoms, respiratory tract infection within 4 weeks of inclusion, significant co-morbid disease that 
was likely to impact on daily activity, or inability to consent. 
Forty-eight patients consented to participate. Four patients were subsequently found to have 
diagnoses other than IPF and five patients withdrew consent before undertaking any assessments. In 
total, thirty-nine participants underwent clinical assessment and daily activity measurement. All 
included patients were clinically stable during the measurement period. 
Clinical Assessments 
Prior to activity measurement, all participants underwent 6MWD, and pulmonary function tests 
(PFTs). PFTs were performed in the pulmonary function laboratory at the Norfolk and Norwich 
Hospital (CareFusion Masterscreen PFT system). The results of the forced vital capacity (FVC) and 
diffusing capacity of carbon monoxide (DLCO) were recorded as a percentage of predicted values. 
Patients were stratified by disease severity, with severe disease defined as an FVC <55% or DLCO 
<40%12. The 6MWD was performed without supplemental oxygen and in accordance with ATS 
guidelines13. Baseline and minimum saturations during the 6MWD were recorded. Participants 
completed a number of questionnaires: the MRC dyspnoea scale14 was performed to determine their 
severity of dyspnoea, the Hospital Anxiety and Depression Scale (HADS), which is able to identify and 
quantify two common forms of psychological problems in patients with ILD15, the Fatigue 
Assessment Scale (FAS) 16 and the Kings Brief Interstitial Lung Disease (KBILD) questionnaire 17. 
Mortality data for participants was recorded from their hospital records for 24 months following 
participation. 
Measurement of daily activity 
All participants were asked to wear a wrist-worn, tri-axial accelerometer (GENEActiv actiwatch; 
GENEActiv, Cambridgeshire, UK) on their non-dominant wrist continuously for at least 7 consecutive 
days. The sampling frequency of the device was 50Hz. Data from the devices was defined as valid if 
there was at least 16 hours of data on at least 2 week days and 2 weekend days18. Accelerometer 
data was processed according to acceleration intensity and time in sedentary behaviour. Activity 
data was analysed using the R-statistics package GGIR19. Mean acceleration intensity (the single 
vector magnitude of the combined accelerations in all three axes recorded by the device) in the 
most active 5 hour period in each day was recorded in milli-g units (M5) and averaged across each 
day of valid wear time. Time in sedentary behaviour was calculated by converting raw data from the 
GENEActiv devices to 15 second epoch files by the GENEActiv PC software and then analysed using a 
sedentary sphere custom spreadsheet (available from the authors of the original paper11). 
Statistical Analysis 
Data analysis was undertaken using SPSS Statistics version 22 (IBM Corp, Illinois, USA). Data was 
divided into terciles by average minutes in sedentary behaviours per day. Comparison of M5 and 
mean daily time in sedentary behaviours were compared after stratifying IPF severity by lung 
function values, using FVC <55% predicted or DLCO <40% predicted as per previous trials12. Time in 
sedentary behaviour was analysed by day of the week to investigate differences between weekdays 
and weekend days. 
Bivariate analyses between predictor variables (age, FVC % predicted, DLCO % predicted, 6MWD, 
MRC dyspnoea score, HADS score, KBILD and FAS) and both M5 values and time in sedentary 
behaviours were performed. The M5 variable was logarithmically-transformed to normalise 
distribution (other variables were normally distributed). Subsequently, variables with p<0.2 in the 
bivariate analysis were introduced into a multivariate linear regression model with stepwise removal 
of non-significant predictors. Partial r2 values for significant predictors remaining within the final 
model were calculated to determine variability explained by each predictor. 
Mortality data for the 12- and 24-month period following study participation was analysed using the 
Kaplan-Meier estimator, with survival results displayed for each tercile of time spent in sedentary 
behaviours. 
 
Results 
Of the 39 patients who wore an accelerometer, 35 devices recorded valid data (89.7%). Four devices 
contained insufficient data to analyse; two devices failed (battery insufficiently charged) and two 
devices were removed prematurely by participants before sufficient data had been collected.  
Demographic and activity data for the participants are shown in Table 1. No patients were receiving 
supplemental oxygen at the time of assessment. Eleven patients (31.4%) had severe disease. 
Exercise tolerance (6MWD) was moderately reduced. HADS scores were higher in the highest two 
terciles of time in sedentary behaviours. No differences in FAS scores were seen across each tercile 
and KBILD scores decreased across terciles of increasing time in sedentary behaviour suggesting 
worse health-related quality of life. The most sedentary group spent 195.4 minutes more time in 
sedentary behaviours per day on average than the least sedentary group. A trend towards higher 
accelerometer outputs during the most active 5 hours each day was seen, with the most sedentary 
group showing mean acceleration value of 36.9milli-g compared with 56.0milli-g in the least 
sedentary group. There was a moderate negative correlation between M5 values and time in 
sedentary behaviour per day in the bivariate correlation (r=-0.366, p=0.030). No differences were 
seen in M5 values or time in sedentary behaviour between patients with and without severe disease 
(Figure 1). No difference in time spent in sedentary behaviour was seen between any days of the 
week (Figure 2). 
The outcomes from the bivariate correlation and the multivariate regression model are shown in 
Table 2. None of the clinical measures (lung function, 6MWD or questionnaire results) showed a 
relationship with time in sedentary behaviour. Only M5 values from the accelerometer showed 
significant correlation with time in sedentary behaviour; in the regression analysis this was the only 
variable that satisfied the requirements for inclusion in the model. This variable was responsible for 
only 13.4% of the variability in time in sedentary behaviour seen (r2 = 0.134). When predicting 
physical activity during the most active 5 hours, the 6MWD and FVC were the only variables that 
remained in the regression model, with 23.5% of the variability in the M5 value was predicted by 
these two variables. 
Mortality data for the two years following participation in the study is shown in Figure 3. Six (17.1%) 
patients died within one year of completing the study. Nine patients (25.7%) died within two years. 
There was a tendency towards higher mortality in the two most sedentary terciles, although there 
was no significant statistical difference between the three terciles. 
 
Discussion 
To our knowledge this is the first study to investigate sedentary behaviours in IPF patients using a 
wrist-worn, three-axis accelerometry devices. The results suggest these devices can feasibly measure 
time in sedentary behaviour and activity over a period of at least seven days in patients with chronic 
respiratory disease. No difference was seen in duration of sedentary behaviour by day of the week, 
suggesting that it is not necessary to measure both weekend and week days in retired patients with 
IPF. Although we did not compare multiple devices here (e.g. step counters or hip-worn 
accelerometers), in previous studies wrist-worn devices have been shown to be acceptable to 
wearers20, leading to greater wear-time21. Concerns about lack of agreement between waist and 
wrist accelerometers have been raised, but used appropriately the classification of activity intensity 
has been shown to be in the same range as those reported for waist-worn devices22,23. Furthermore, 
only the wrist-worn GENEActiv device has been used so far to measure time in sedentary 
behaviours11,24. 
There was a wide spread of time spent in sedentary behaviours in the group. There were insufficient 
participants in this trial to draw firm conclusions about whether sedentary behaviours influence 
mortality, but the trend towards increased mortality at both one and two years in the more 
sedentary participants raises the possibility of an association. Previous studies have shown that 
people with greater sedentary time have poorer health outcomes8. Furthermore, the cohort here 
appeared relatively sedentary compared to populations of equivalent age. One study measuring 
sedentary behaviours and monitoring mortality and morbidity in 93,676 women in the United States 
of America reported that 25.9% of participants aged 70-79, similar to the age range included here, 
spent less than 4 hours per day in sedentary behaviours25. In addition, participants spending less 
than 4 hours per day in sedentary behaviours had better outcomes than those spending more than 
11 hours in sedentary behaviour per day (similar to the mean time spent in sedentary behaviours in 
tercile 3 of our cohort, of 656.7 minutes per day). Reducing sedentary behaviours may be beneficial, 
but predicting those patients in clinic who are likely to be highly sedentary may be difficult. 
Furthermore it will be difficult for patients with severe disease to increase even light activity and is 
unlikely to affect prognosis in these cases. No clinical measures within this group showed a 
relationship with time in sedentary behaviour, whereas variability in measures of activity (M5) was 
predicted well by 6MWD; direct assessment of sedentary behaviours in free living using monitoring 
devices may be required.  
We deliberately avoided using pre-determined thresholds for activity vigour using the GENEActiv 
devices as these thresholds are likely to vary highly between individual patients depending upon 
disease severity. The measure of physical activity we chose for analysis was the M5 value; it was felt 
that this measure would best reflect the peak activity of the subject without being influenced by the 
relatively longer periods of sleep or sedentary behaviours. Without previous validation with indirect 
calorimetry or double-labelled water as a comparison in patients with ILDs, the classification of 
physical activity vigour using these devices may be inaccurate. By contrast, the definition of 
sedentary behaviour should not be significantly different between healthy individuals and patients 
such as those included in this study, and therefore should be measured equally accurately by the 
GENEActiv device as when used in healthy volunteers11,24. As a result, the measurement of sedentary 
time should not need revalidating in this population as the use of accelerometers to define exercise 
intensity would. 
No studies have been performed to validate accelerometers as a measure of physical activity energy 
expenditure in IPF, although they have been performed in COPD. This showed that the SenseWear 
Pro armband could accurately measure energy expenditure in metabolic equivalents in laboratory 
conditions, albeit with a tendency to underestimate energy expenditure when walking and over-
estimate when performing daily activities10. Studies that have used accelerometers in IPF have used 
proximally worn devices3,26,27. Wallaert and colleagues used the SenseWear Pro armband and 
showed that there was a 45% decrease in exercise expenditure >2.5 metabolic equivalents per day 
compared with a sedentary healthy population, as well as an association between lower steps per 
day and increased mortality3. Bahmer and colleagues also used the SenseWear Pro armband to 
identify that fatigue, alongside 6MWD, were the strongest predictors of activity measured as steps 
per day27. In the paper by Wallaert and colleagues, 6MWD predicted 11% of the variability in 
number of steps per day, similar to the 13.7% in variability in M5 values explained by 6MWD in our 
study. Finally, Nakayama and colleagues used a waist-worn uniaxial accelerometer that had not 
previously been used in IPF patients, showing that only 70.6 minutes per day were spent performing 
any activity. This was the only study to describe potentially sedentary behaviours; 611.2 minutes per 
day were spent at a level of movement too low to measure as activity (<1 magnitude of movement, 
corresponding with any activity less intense than light activity)26. Because their device couldn’t 
determine posture it is impossible to determine whether all of this time was truly sedentary. The 
time spent at this level of inactivity was slightly higher than observed in our participants (mean time 
in sedentary behaviour per day 551.7 minutes per day). The difference in time seen may relate to 
the different demographic studied, although the cohort in our study was older than the Japanese 
cohort (mean age 75.1 years compared with 68.3 years). Alternatively, inability to wear the waist-
worn device at all times may have caused under-recording of time spent performing sedentary 
behaviours but non-wear time was not reported in the paper.  
The measurement of sedentary behaviour in patients with IPF and other chronic respiratory diseases 
may become increasingly important. Whilst the difficulty of increasing physical activity to the point 
of meeting recommended guidelines has been discussed in COPD patients9, the same problems 
affect patients with IPF. Chronic dyspnoea and fatigue limit exercise in this group27, and increasing 
peak exercise to spend more time performing at least moderate exercise may be unreasonable. 
There is some evidence to suggest that improving time in light activity compared with sedentary 
behaviour, even when not meeting recommended levels of moderate and vigorous intensity 
exercise, can improve various outcomes in healthy populations28; the benefits of increasing light 
physical activity and reducing sedentary behaviours in IPF and other chronic diseases warrants 
further investigation.  
This study had a number of strengths. The IPF cohort analysed was well-characterised, excluded co-
morbidities that may have affected daily activity, and recording anxiety and depression scores. The 
number of participants providing valid data was high. The use of three-axis, wrist-worn 
accelerometer was able to provide large amounts of data, with participants wearing the devices for 
at least 7 days. The results reveal the sedentary behaviours of patients with IPF for the first time. 
There are also some weaknesses. The small number of participants within this feasibility study limits 
the ability to conclude whether increased time spent in sedentary behaviours is associated with 
worse outcomes. Further investigation with larger cohorts will be needed to investigate this 
association. There was a small range of HADS scores in our sample and therefore we may have 
underestimated the influence of this outcome on activity. Other factors that may help predict 
activity and sedentary behaviours, such as motivation and socio-economic factors, were not 
explored in this group.  
In conclusion, the wrist-worn GENEActiv accelerometer can feasibly record sedentary behaviours in 
IPF patients. IPF patients spent significant periods of their day in sedentary behaviours. Of routine 
clinical measurements 6MWD was the best predictor of activity. A moderate inverse relationship 
between activity and sedentary behaviours was seen, but no clinical measurements could predict 
time in sedentary behaviour. Reducing sedentary time spent in and increasing time in light activities 
may be beneficial in IPF as it may improve outcomes and be a more achievable goal in patients who 
are markedly limited by their respiratory disease.  
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